Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng for CNY 4 million on March 27, 2016. Under the terms of the deal, Yan Xijun plans to transfer 5% stake to Yan Kaijing for CNY 1.8 million and Wu Nai Feng plans to transfer 6% stake to Li Yunhui for CNY 2.16 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.01 CNY | -1.74% |
|
-4.48% | -23.56% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.56% | 2.73B | |
+33.13% | 6.03B | |
-31.17% | 3.78B | |
-0.30% | 3.24B | |
-10.11% | 2.32B | |
+40.27% | 1.93B | |
+40.53% | 1.5B | |
-25.53% | 1.48B | |
-12.05% | 1.46B | |
+40.95% | 1.33B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. from Yan Xijun and Wu Nai Feng for CNY 4 million.